Newsletter | June 23, 2025

06.23.25 -- Expanding Biologics Delivery Options Via Oral Devices

FEATURED EDITORIAL

Expanding Biologics Delivery Options Via Oral Devices

In this episode of Supplier Horizons, host Tom von Gunden talks with CEO Karsten Lindhardt of oral platform technology developer Biograil about capsule-enclosed combination devices that offer patients convenience while bolstering patient compliance.

Lesser Known Keys To Biopharma Supplier Engagement

In this article, Fran DeGrazio lays out ways for biopharma companies developing and commercializing combination products and other drug delivery devices to ensure that their product requirements and related documentation needs are well met by suppliers of materials, devices, components, and services. 

INDUSTRY INSIGHTS

Simplify The Move From Vial To Prefilled Syringe

Explore market trends that could impact the lifecycle strategies for your drug product and its packaging. Careful selection of drug packaging can save time and support a successful transition to new formats.

Rapid Oral Administration Of Migraine Treatments

Examine the case study and learn how formulating an orally disintegrating tablet (ODT) created a convenient dosage form with a shorter Tmax for the treatment of acute migraine.

Streamline Fill And Finish For Ready-To-Use Cartridges

An optimized nest design for pre-fillable cartridges was designed using numerical simulation and data analytics to improve efficiency in pharmaceutical production.

Characterizing Injection Factors And Their Impact On System Function

The transition of intravenous in-clinic chronic disease therapies to large volume subcutaneous injections in alternate settings has created an evolving roster of new formulations and treatment options.

SOLUTIONS

Organ On A Chip: Advancing In Vitro Modeling

Nasal Spray Development And Manufacturing Services